Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection

Simon R. Carlile; Jenna Shiels; Lauren Kerrigan; Rebecca Delaney; Julianne Megaw; Brendan F. Gilmore; Sinead Weldon; John P. Dalton; Clifford C. Taggart

doi:10.1038/s41598-019-42537-8

Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection

Simon R. Carlile, Jenna Shiels, Lauren Kerrigan, Rebecca Delaney, Julianne Megaw, Brendan F. Gilmore, Sinead Weldon, John P. Dalton, Clifford C. Taggart

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

125 Downloads (Pure)

Abstract

We investigated the anti-inflammatory and antibacterial activities of Hc-cath, a cathelicidin peptide derived from the venom of the sea snake, Hydrophis cyanocyntus, using in vivo models of inflammation and infection. Hc-cath function was evaluated in in vitro, in vivo in the wax moth, Galleria mellonella, and in mouse models of intraperitoneal and respiratory Pseudomonas aeruginosa infection. Hc-Cath downregulated LPS-induced pro-inflammatory responses in macrophages and significantly improved the survival of P. aeruginosa infected G. mellonella over a 5-day period. We also demonstrated, for the first time, that Hc-cath can modulate inflammation in a mouse model of LPS-induced lung inflammation by significantly reducing the release of the pro-inflammatory cytokine and neutrophil chemoattractant, KC, resulting in reduced cellular infiltration into the lungs. Moreover, Hc-cath treatment significantly reduced the bacterial load and inflammation in mouse models of P. aeruginosa intraperitoneal and respiratory infection. The effect of Hc-cath in our studies highlights the potential to develop this peptide as a candidate for therapeutic development.

Original language	English
Article number	6071
Journal	Scientific Reports
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41598-019-42537-8
Publication status	Published - 15 Apr 2019

Access to Document

10.1038/s41598-019-42537-8

Sea snake cathelicidin (Hc-cath) exerts a protective efect in mouse models of lung infammation and infection
© 2019 The Authors. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Te images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Final published version, 1.44 MBLicence: CC BY

Fingerprint Dive into the research topics of 'Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection'. Together they form a unique fingerprint.

Cite this

@article{c716e13253c04d7a8e229c9e86ffaf16,

title = "Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection",

abstract = "We investigated the anti-inflammatory and antibacterial activities of Hc-cath, a cathelicidin peptide derived from the venom of the sea snake, Hydrophis cyanocyntus, using in vivo models of inflammation and infection. Hc-cath function was evaluated in in vitro, in vivo in the wax moth, Galleria mellonella, and in mouse models of intraperitoneal and respiratory Pseudomonas aeruginosa infection. Hc-Cath downregulated LPS-induced pro-inflammatory responses in macrophages and significantly improved the survival of P. aeruginosa infected G. mellonella over a 5-day period. We also demonstrated, for the first time, that Hc-cath can modulate inflammation in a mouse model of LPS-induced lung inflammation by significantly reducing the release of the pro-inflammatory cytokine and neutrophil chemoattractant, KC, resulting in reduced cellular infiltration into the lungs. Moreover, Hc-cath treatment significantly reduced the bacterial load and inflammation in mouse models of P. aeruginosa intraperitoneal and respiratory infection. The effect of Hc-cath in our studies highlights the potential to develop this peptide as a candidate for therapeutic development.",

author = "Carlile, {Simon R.} and Jenna Shiels and Lauren Kerrigan and Rebecca Delaney and Julianne Megaw and Gilmore, {Brendan F.} and Sinead Weldon and Dalton, {John P.} and Taggart, {Clifford C.}",

year = "2019",

month = apr,

day = "15",

doi = "10.1038/s41598-019-42537-8",

language = "English",

volume = "9",

journal = "Nature Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection. / Carlile, Simon R.; Shiels, Jenna; Kerrigan, Lauren ; Delaney, Rebecca ; Megaw, Julianne ; Gilmore, Brendan F.; Weldon, Sinead; Dalton, John P.; Taggart, Clifford C.

In: Scientific Reports, Vol. 9, No. 1, 6071, 15.04.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection

AU - Carlile, Simon R.

AU - Shiels, Jenna

AU - Kerrigan, Lauren

AU - Delaney, Rebecca

AU - Megaw, Julianne

AU - Gilmore, Brendan F.

AU - Weldon, Sinead

AU - Dalton, John P.

AU - Taggart, Clifford C.

PY - 2019/4/15

Y1 - 2019/4/15

N2 - We investigated the anti-inflammatory and antibacterial activities of Hc-cath, a cathelicidin peptide derived from the venom of the sea snake, Hydrophis cyanocyntus, using in vivo models of inflammation and infection. Hc-cath function was evaluated in in vitro, in vivo in the wax moth, Galleria mellonella, and in mouse models of intraperitoneal and respiratory Pseudomonas aeruginosa infection. Hc-Cath downregulated LPS-induced pro-inflammatory responses in macrophages and significantly improved the survival of P. aeruginosa infected G. mellonella over a 5-day period. We also demonstrated, for the first time, that Hc-cath can modulate inflammation in a mouse model of LPS-induced lung inflammation by significantly reducing the release of the pro-inflammatory cytokine and neutrophil chemoattractant, KC, resulting in reduced cellular infiltration into the lungs. Moreover, Hc-cath treatment significantly reduced the bacterial load and inflammation in mouse models of P. aeruginosa intraperitoneal and respiratory infection. The effect of Hc-cath in our studies highlights the potential to develop this peptide as a candidate for therapeutic development.

AB - We investigated the anti-inflammatory and antibacterial activities of Hc-cath, a cathelicidin peptide derived from the venom of the sea snake, Hydrophis cyanocyntus, using in vivo models of inflammation and infection. Hc-cath function was evaluated in in vitro, in vivo in the wax moth, Galleria mellonella, and in mouse models of intraperitoneal and respiratory Pseudomonas aeruginosa infection. Hc-Cath downregulated LPS-induced pro-inflammatory responses in macrophages and significantly improved the survival of P. aeruginosa infected G. mellonella over a 5-day period. We also demonstrated, for the first time, that Hc-cath can modulate inflammation in a mouse model of LPS-induced lung inflammation by significantly reducing the release of the pro-inflammatory cytokine and neutrophil chemoattractant, KC, resulting in reduced cellular infiltration into the lungs. Moreover, Hc-cath treatment significantly reduced the bacterial load and inflammation in mouse models of P. aeruginosa intraperitoneal and respiratory infection. The effect of Hc-cath in our studies highlights the potential to develop this peptide as a candidate for therapeutic development.

U2 - 10.1038/s41598-019-42537-8

DO - 10.1038/s41598-019-42537-8

M3 - Article

VL - 9

JO - Nature Scientific Reports

JF - Nature Scientific Reports

SN - 2045-2322

IS - 1

M1 - 6071

ER -